C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 7/23 (2006.01) A61K 31/16 (2006.01) A61K 31/27 (2006.01) A61K 31/275 (2006.01) A61K 31/33 (2006.01) A61K 38/09 (2006.01) C07C 257/18 (2006.01) C07C 271/22 (2006.01) C07D 207/27 (2006.01) C07D 209/08 (2006.01) C07D 211/14 (2006.01) C07D 213/56 (2006.01) C07D 213/60 (2006.01) C07D 213/61 (2006.01) C07D 213/64 (2006.01) C07D 213/75 (2006.01) C07D 213/80 (2006.01) C07D 213/84 (2006.01) C07D 215/22 (2006.01) C07D 231/56 (2006.01) C07D 233/26 (2006.01) C07D 233/32 (2006.01) C07D 233/61 (2006.01) C07D 233/64
Patent
CA 2238570
New LH-RH antagonists are disclosed, in particular peptidomimetics and peptides modified in a side chain, their salts with pharmaceutically acceptable acids and a process for preparing these LH-RH antagonists and their salts. The disclosed peptides represent analogues of the luteinising hormone releasing hormone (LH-RH). The disclosed compounds have a high antagonistic power and are free of undesirable side effects, in particular edematogenic effects.
L'invention concerne de nouveaux antagonistes de l'hormone libérant l'hormone lutéinisante (LH-RH), notamment des agents peptidomimétiques et des peptides modifiés dans une chaîne latérale, les sels de ceux-ci avec des acides pharmaceutiquement acceptables et un procédé de préparation des antagonistes de LH-RH et de leurs sels. Ces peptides constituent des analogues de l'hormone libérant l'hormone lutéinisante (LH-RH). Ces composés sont fortement antagonistes et dépourvus d'effets secondaires indésirables, tout particulièrement d'effets oedématogènes.
Beckers Thomas
Bernd Michael
Charpentier Patricia-Marie
Emig Peter-Paul
Klenner Thomas
Asta Medica Aktiengesellschaft
Marks & Clerk
Zentaris Gmbh
LandOfFree
New lh-rh antagonists with improved effectiveness does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with New lh-rh antagonists with improved effectiveness, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and New lh-rh antagonists with improved effectiveness will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1810313